Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
Open Access
- 15 March 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (3) , e0172864
Abstract
The ColonCancerCheck screening program for colorectal cancer (CRC) in Ontario, Canada, is considering switching from biennial guaiac fecal occult blood test (gFOBT) screening between age 50–74 years to the more sensitive, but also less specific fecal immunochemical test (FIT). The aim of this study is to estimate whether the additional benefits of FIT screening compared to gFOBT outweigh the additional costs and harms. We used microsimulation modeling to estimate quality adjusted life years (QALYs) gained and costs of gFOBT and FIT, compared to no screening, in a cohort of screening participants. We compared strategies with various age ranges, screening intervals, and cut-off levels for FIT. Cost-efficient strategies were determined for various levels of available colonoscopy capacity. Compared to no screening, biennial gFOBT screening between age 50–74 years provided 20 QALYs at a cost of CAN$200,900 per 1,000 participants, and required 17 colonoscopies per 1,000 participants per year. FIT screening was more effective and less costly. For the same level of colonoscopy requirement, biennial FIT (with a high cut-off level of 200 ng Hb/ml) between age 50–74 years provided 11 extra QALYs gained while saving CAN$333,300 per 1000 participants, compared to gFOBT. Without restrictions in colonoscopy capacity, FIT (with a low cut-off level of 50 ng Hb/ml) every year between age 45–80 years was the most cost-effective strategy providing 27 extra QALYs gained per 1000 participants, while saving CAN$448,300. Compared to gFOBT screening, switching to FIT at a high cut-off level could increase the health benefits of a CRC screening program without considerably increasing colonoscopy demand.Keywords
Funding Information
- Canadian Institutes of Health Research (CA) (CST-85478)
- National Cancer Institute (U01-CA-097426, U01-CA-115953, and U01-CA-152959)
This publication has 41 references indexed in Scilit:
- Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopyBritish Journal of Cancer, 2012
- Colorectal Cancer Screening for Average-Risk North Americans: An Economic EvaluationPLOS Medicine, 2010
- The cost-effectiveness of screening for colorectal cancerCanadian Medical Association Journal, 2010
- Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopyGut, 2009
- A novel hypothesis on the sensitivity of the fecal occult blood testCancer, 2009
- Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levelsBritish Journal of Cancer, 2009
- Bleeding and Perforation After Outpatient Colonoscopy and Their Risk Factors in Usual Clinical PracticeGastroenterology, 2008
- Colorectal cancer screening: A comparison of 35 initiatives in 17 countriesInternational Journal of Cancer, 2007
- Polyp Miss Rate Determined by Tandem Colonoscopy: A Systematic ReviewAmerican Journal of Gastroenterology, 2006
- Guidelines for Pharmacoeconomic StudiesPharmacoEconomics, 1997